Litcius/Paper detail

A review of the latest research on M<sup>pro</sup> targeting SARS-COV inhibitors

Huihui Yang, Jinfei Yang

2021RSC Medicinal Chemistry55 citationsDOIOpen Access PDF

Abstract

in this review. We believe that this review will provide meaningful guidance for the design and development of innovative drugs against COVID-19 and other pathogenic coronaviruses in the future.

Topics & Concepts

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)Drug developmentPandemic2019-20 coronavirus outbreakCoronavirusHighly pathogenicVirologyProteaseDrugDrug discoveryMedicineOutbreakBiologyVirusPharmacologyBioinformaticsInfectious disease (medical specialty)EnzymeDiseasePathologyBiochemistryInfluenza A virus subtype H5N1Computational Drug Discovery MethodsSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies
A review of the latest research on M<sup>pro</sup> targeting SARS-COV inhibitors | Litcius